Cargando…
Chitosan Nanoparticles for Meloxicam Ocular Delivery: Development, In Vitro Characterization, and In Vivo Evaluation in a Rabbit Eye Model
Eye inflammation is considered one of the most common co-morbidities associated with ocular disorders and surgeries. Conventional management of this condition with non-steroidal anti-inflammatory drugs as eye drops is associated with low corneal bioavailability and ocular irritancy. In the current s...
Autores principales: | Mohamed, Hebatallah B., Attia Shafie, Mohamed Ali, Mekkawy, Aml I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148062/ https://www.ncbi.nlm.nih.gov/pubmed/35631479 http://dx.doi.org/10.3390/pharmaceutics14050893 |
Ejemplares similares
-
Evaluation of Different Surface Coating Agents for Selenium Nanoparticles: Enhanced Anti-Inflammatory Activity and Drug Loading Capacity
por: Mekkawy, Aml I, et al.
Publicado: (2022) -
Formulation development, in vitro and in vivo evaluation of chitosan engineered nanoparticles for ocular delivery of insulin
por: Rathore, Priyanka, et al.
Publicado: (2020) -
Chitosan Encapsulated Meloxicam Nanoparticles for Sustained Drug Delivery Applications: Preparation, Characterization, and Pharmacokinetics in Wistar Rats
por: Yegireddy, Muralidhar, et al.
Publicado: (2022) -
Enhanced transdermal delivery of meloxicam by nanocrystals: Preparation, in vitro and in vivo evaluation
por: Yu, Qin, et al.
Publicado: (2018) -
Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies
por: Alhowyan, Adel Ali, et al.
Publicado: (2023)